Moderna And Genevant/Arbutus Settle LNP Patent Dispute For $950m+

Moderna Held Accountable For Infringing Patent With COVID-19 Vaccine

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.